A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole
Nimish Thakore, Erik P. Pioro, Belinda Udeh, Brittany Lapin, Irene Katzan
Topics & Concepts
RiluzoleAmyotrophic lateral sclerosisMedicineCost–utility analysisQuality-adjusted life yearCohortHealth careCost effectivenessDiseaseInternal medicineRisk analysis (engineering)EconomicsEconomic growthAmyotrophic Lateral Sclerosis ResearchParkinson's Disease and Spinal DisordersHealth Systems, Economic Evaluations, Quality of Life